- Home
- LGO vs SAVA Comparison
LGO vs SAVA Comparison
Compare LGO & SAVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LGO
- SAVA
- Stock Information
- Founded
- LGO 1988
- SAVA 1998
- Country
- LGO Canada
- SAVA United States
- Employees
- LGO N/A
- SAVA N/A
- Industry
- LGO
- SAVA Biotechnology: Pharmaceutical Preparations
- Sector
- LGO
- SAVA Health Care
- Exchange
- LGO Nasdaq
- SAVA Nasdaq
- Market Cap
- LGO 100.0M
- SAVA 102.4M
- IPO Year
- LGO 2007
- SAVA N/A
- Fundamental
- Price
- LGO $1.74
- SAVA $2.09
- Analyst Decision
- LGO Strong Buy
- SAVA Hold
- Analyst Count
- LGO 1
- SAVA 1
- Target Price
- LGO $3.70
- SAVA $2.00
- AVG Volume (30 Days)
- LGO 153.1K
- SAVA 486.5K
- Earning Date
- LGO 11-11-2025
- SAVA 11-06-2025
- Dividend Yield
- LGO N/A
- SAVA N/A
- EPS Growth
- LGO N/A
- SAVA N/A
- EPS
- LGO N/A
- SAVA N/A
- Revenue
- LGO $108,526,000.00
- SAVA N/A
- Revenue This Year
- LGO N/A
- SAVA N/A
- Revenue Next Year
- LGO $54.96
- SAVA N/A
- P/E Ratio
- LGO N/A
- SAVA N/A
- Revenue Growth
- LGO N/A
- SAVA N/A
- 52 Week Low
- LGO $1.12
- SAVA $1.15
- 52 Week High
- LGO $2.84
- SAVA $33.98
- Technical
- Relative Strength Index (RSI)
- LGO 73.41
- SAVA 43.27
- Support Level
- LGO $1.32
- SAVA $2.04
- Resistance Level
- LGO $1.56
- SAVA $2.19
- Average True Range (ATR)
- LGO 0.08
- SAVA 0.09
- MACD
- LGO 0.02
- SAVA -0.02
- Stochastic Oscillator
- LGO 91.74
- SAVA 13.89
About LGO Largo Inc.
Largo Inc is committed to the production and supply of high-quality vanadium products. The company is also focused on the advancement of renewable energy storage solutions through Largo Clean Energy and its vanadium redox flow battery technology. The Company is engaged in the mining, exploration, and development of mineral properties, predominantly in Brazil, through which it produces and supplies vanadium products VPURE Flake, VPURE+ Flake, and VPURE+ Powder. The company has operating segments: sales & trading, mine properties, which generates key revenue, corporate, exploration and evaluation properties, Clean Energy, and Largo Physical Vanadium.
About SAVA Cassava Sciences Inc.
Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease; and investigational diagnostic product candidate is called SavaDx and it is a novel way to detect the presence of Alzheimer's disease from a small sample of blood, possibly years before the overt appearance of clinical symptoms. It is currently conducting two randomized placebo-controlled Phase 3 clinical trials of oral simufilam in patients with Alzheimer's disease dementia. It has one business segment: the development of novel drugs and diagnostics.